Abstract:
Objective: To observe the influence of Siqikang(bacillus calmate guerin-polysaccharide nucleinic acid: BCG-PSN) combined specific desensitization(SIT) upon serum IgE and IL-4 of the bronchial asthmatic patients during the remission stage.
Methods: 90 cases of the bronchial asthmatic patients during the remission stage were selected and randomly divided into three groups,to who respectively was given the treatment of Siqikang(BCG-PSN),SIT and Siqikang(BCG-PSN) combined SIT(conbined treatment group).The changes in serum IgE and IL-4 were compared between these 3 groups.
Results: After 36 d treatment,IL-4 level of the patients in the combined treatment group started to decrease,and IL-4 level was significantly lower in 108 d(6.50±8.30)ng·L
-1,there was a significant difference between the combined group and the other two groups(P<0.05),and there was a decrease in total serum IgE(261±329)mg·L
-1.
Conclusion: The combined treatment of Siqikang(BCG-PSN) and SIT can not only effectively reduce the the inflammatory factors in body of bronchial asthmatic patients during the remission stage,but also have faster effectiveness.